Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nicholas S Berry"'
Autor:
Donald A Berry, Andrew Ip, Brett E Lewis, Scott M Berry, Nicholas S Berry, Mary MrKulic, Virginia Gadalla, Burcu Sat, Kristen Wright, Michelle Serna, Rashmi Unawane, Katerina Trpeski, Michael Koropsak, Puneet Kaur, Zachary Sica, Andrew McConnell, Urszula Bednarz, Michael Marafelias, Andre H Goy, Andrew L Pecora, Ihor S Sawczuk, Stuart L Goldberg
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255228 (2021)
ObjectivesThe development of a prognostic mortality risk model for hospitalized COVID-19 patients may facilitate patient treatment planning, comparisons of therapeutic strategies, and public health preparations.MethodsWe retrospectively reviewed the
Externí odkaz:
https://doaj.org/article/0544c34f8de74d10831452a6e428d4c2
Autor:
Andrew Ip, Donald A Berry, Eric Hansen, Andre H Goy, Andrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Scott M Berry, Nicholas S Berry, Shivam Mathura, Ihor S Sawczuk, Noa Biran, Ronaldo C Go, Steven Sperber, Julia A Piwoz, Bindu Balani, Cristina Cicogna, Rani Sebti, Jerry Zuckerman, Keith M Rose, Lisa Tank, Laurie G Jacobs, Jason Korcak, Sarah L Timmapuri, Joseph P Underwood, Gregory Sugalski, Carol Barsky, Daniel W Varga, Arif Asif, Joseph C Landolfi, Stuart L Goldberg
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237693 (2020)
Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this retrospective observational cohort study drawn from electronic health r
Externí odkaz:
https://doaj.org/article/0eb4769173b44ac7b0878cbcbb1584b3
Publikováno v:
Clinical Trials. 19:490-501
Background Multi-arm platform trials investigate multiple agents simultaneously, typically with staggered entry and exit of experimental treatment arms versus a shared control arm. In such settings, there is considerable debate whether to limit analy
Autor:
Sharon D Yeatts, Lydia D Foster, William G Barsan, Nicholas S Berry, Clifton W Callaway, Roger J Lewis, Benjamin R Saville, Robert Silbergleit, Jeffrey A Kline
Publikováno v:
Clin Trials
Background/Aims Fibrinolytic therapy with tenecteplase has been proposed for patients with pulmonary embolism but the optimal dose is unknown. Higher-than-necessary dosing is likely to cause excess bleeding. We designed an adaptive clinical trial to
Autor:
Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, Najib M Rahman, Gail Hayward, Duncan B Richards, Jienchi Dorward, David M Lowe, Joseph F Standing, Judith Breuer, Saye Khoo, Stavros Petrou, Kerenza Hood, Jonathan S Nguyen-Van-Tam, Mahendra G Patel, Benjamin R Saville, Joe Marion, Emma Ogburn, Julie Allen, Heather Rutter, Nick Francis, Nicholas P B Thomas, Philip Evans, Melissa Dobson, Tracie-Ann Madden, Jane Holmes, Victoria Harris, May Ee Png, Mark Lown, Oliver van Hecke, Michelle A Detry, Christina T Saunders, Mark Fitzgerald, Nicholas S Berry, Lazaro Mwandigha, Ushma Galal, Sam Mort, Bhautesh D Jani, Nigel D Hart, Haroon Ahmed, Daniel Butler, Micheal McKenna, Jem Chalk, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer C Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Andrew Carson-Stevens, Ly-Mee Yu, Paul Little, Akosua A Agyeman, Tanveer Ahmed, Damien Allcock, Adrian Beltran-Martinez, Oluseye E Benedict, Nigel Bird, Laura Brennan, Julianne Brown, Gerard Burns, Mike Butler, Zelda Cheng, Ruth Danson, Nigel de Kare-Silver, Devesh Dhasmana, Jon Dickson, Serge Engamba, Stacey Fisher, Robin Fox, Eve Frost, Richard Gaunt, Sarit Ghosh, Ishtiaq Gilkar, Anna Goodman, Steve Granier, Aleksandra Howell, Iqbal Hussain, Simon Hutchinson, Marie Imlach, Greg Irving, Nicholas Jacobsen, James Kennard, Umar Khan, Kyle Knox, Christopher Krasucki, Tom Law, Rem Lee, Nicola Lester, David Lewis, James Lunn, Claire I. Mackintosh, Mehul Mathukia, Patrick Moore, Seb Morton, Daniel Murphy, Rhiannon Nally, Chinonso Ndukauba, Olufunto Ogundapo, Henry Okeke, Amit Patel, Kavil Patel, Ruth Penfold, Satveer Poonian, Olajide Popoola, Alexander Pora, Vibhore Prasad, Rishabh Prasad, Omair Razzaq, Scot Richardson, Simon Royal, Afsana Safa, Satash Sehdev, Tamsin Sevenoaks, Divya Shah, Aadil Sheikh, Vanessa Short, Baljinder S Sidhu, Ivor Singh, Yusuf Soni, Chris Thalasselis, Pete Wilson, David Wingfield, Michael Wong, Maximillian N J Woodall, Nick Wooding, Sharon Woods, Joanna Yong, Francis Yongblah, Azhar Zafar
Publikováno v:
PANORAMIC Trial Collaborative Group, Butler, C C, Hobbs, F D R, Gbinigie, O A, Rahman, N M, Hayward, G, Richards, D B, Dorward, J, Lowe, D M, Standing, J F, Breuer, J, Khoo, S, Petrou, S, Hood, K, Nguyen-Van-Tam, J S, Patel, M G, Saville, B R, Marion, J, Ogburn, E, Allen, J, Rutter, H, Francis, N, Thomas, N P B, Evans, P, Dobson, M, Madden, T-A, Holmes, J, Harris, V, Png, M E, Lown, M, van Hecke, O, Detry, M A, Saunders, C T, Fitzgerald, M, Berry, N S, Mwandigha, L, Galal, U, Mort, S, Jani, B D, Hart, N D, Ahmed, H, Butler, D, McKenna, M, Chalk, J, Lavallee, L, Hadley, E, Cureton, L, Benysek, M, Andersson, M, Coates, M & Barrett, S 2023, ' Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial ', The Lancet, vol. 401, no. 10373, pp. 281-293 . https://doi.org/10.1016/S0140-6736(22)02597-1
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee6937dbf90341fd2ff687fe41c3d612
https://hdl.handle.net/10023/27412
https://hdl.handle.net/10023/27412
Autor:
Nicole D Zantek, Marie E Steiner, John M VanBuren, Roger J Lewis, Nicholas S Berry, Kert Viele, Elizabeth Krachey, J Michael Dean, Stacy Nelson, Philip C Spinella
Publikováno v:
Clinical trials (London, England).
Background: Platelet transfusion is a potentially life-saving therapy for actively bleeding patients, ranging from those undergoing planned surgical procedures to those suffering unexpected traumatic injuries. Platelets are currently stored at room t
Publikováno v:
Statistical Analysis and Data Mining
Handwritten documents can be characterized by their content or by the shape of the written characters. We focus on the problem of comparing a person's handwriting to a document of unknown provenance using the shape of the writing, as is done in foren
Autor:
Scott M. Berry, Brett E. Lewis, Virginia Gadalla, Michael Marafelias, Andrew McConnell, Andrew Ip, Andrew L. Pecora, Donald A. Berry, Ihor S. Sawczuk, Puneet Kaur, Zachary Sica, Urszula Bednarz, Michael Koropsak, Mary Mrkulic, Michelle Serna, Burcu Sat, Stuart L. Goldberg, Kristen Wright, Katerina Trpeski, Nicholas S. Berry, Rashmi Unawane, Andre Goy
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255228 (2021)
BASE-Bielefeld Academic Search Engine
PLoS ONE
BASE-Bielefeld Academic Search Engine
PLoS ONE
Objectives The development of a prognostic mortality risk model for hospitalized COVID-19 patients may facilitate patient treatment planning, comparisons of therapeutic strategies, and public health preparations. Methods We retrospectively reviewed t
Autor:
Andre Goy, Joseph P. Underwood, Ihor S. Sawczuk, Noa Biran, Andrew Ip, Eric Hansen, Brittany A Sinclaire, Arif Asif, Steven J. Sperber, Stuart L. Goldberg, Lisa Tank, Keith M. Rose, Donald A. Berry, Jerry Zuckerman, Andrew L. Pecora, Nicholas S. Berry, Carol L. Barsky, Sarah L. Timmapuri, Joseph Landolfi, Rani Sebti, Gregory Sugalski, Jason Korcak, Urszula Bednarz, Daniel W. Varga, Cristina Cicogna, Shivam Mathura, Bindu Balani, Scott M. Berry, Michael Marafelias, Laurie G Jacobs, Ronaldo C. Go, Julia A. Piwoz
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237693 (2020)
PLOS ONE, 15(8):e0237693
BASE-Bielefeld Academic Search Engine
PLoS ONE
PLOS ONE, 15(8):e0237693
BASE-Bielefeld Academic Search Engine
PLoS ONE
BackgroundHydroxychloroquine has been touted as a COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has been proposed as a treatment of critically ill patients.ObjectiveTo describe the association between mortality and hydroxychloroquine or toci